Janssen

STELARA

Manufacturer:

Janssen

Stelara HCPCS:

J3358

HCPCS Code Descriptor:

Ustekinumab, for intravenous injection, 1 mg

Category:

J Code

Stelara NDCs:

57894-0054-27

Primary Type:

Immunology:Anti-TNF

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Stelara CPT Codes:

Potential CPT administration codes for Stelara can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Stelara:

STELARA is an Immunology:Anti-TNF drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J3358 is aligned to the drug STELARA.

Stelara for intravenous infusion is a medication often given to patients with autoimmune conditions such as Crohn’s disease and ulcerative colitis. Stelara is thought to work by blocking the proteins IL-12 and IL-23 in the body, which may cause inflammation. Stelara may help relieve a variety of symptoms, such as inflammation, pain, swelling, and skin symptoms.

ACCESS PRICING AND MORE BY REGISTERING

J3358 Added Date:

January 1, 2018

J3358 Effective Date:

January 1, 2018

J3358 Termination Date:

HCPCS Active

Stelara billing and coding information can be found through Janssen at the link below:
Stelara patient assistance information can be found through the Johnson and Johnson Patient Assistance Foundation at the URL: http://www.jjpaf.org/
STELARA prescribing information can be found at the link below:
Information regarding STELARA’s side effects can be found at MedlinePlus